These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 793703)

  • 1. Clinical immunosuppression with antilymphocyte globulin.
    Stiller CR
    Can Med Assoc J; 1976 Dec; 115(12):1190-1. PubMed ID: 793703
    [No Abstract]   [Full Text] [Related]  

  • 2. The adjunctive value of equine antithymocyte membrane globulin in a randomized study of patients undergoing cadaveric renal transplantation.
    Diethelm AG; Blackstone E; Whelchel JD; Pass RF; Chambers L; Phillips SJ; Thiry C
    Transplant Proc; 1979 Mar; 11(1):27-30. PubMed ID: 377644
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithymocyte globulin (ATG) dosage and graft survival in renal transplantation.
    Kountz SL; Butt KH; Rao TK; Zielinski CM; Rafi M; Schultz JR
    Transplant Proc; 1977 Mar; 9(1):1023-5. PubMed ID: 325728
    [No Abstract]   [Full Text] [Related]  

  • 4. Superior renal allograft survival and decreased rejection with early high-dose and sequential multi-species antilymphocyte globulin therapy.
    Thomas F; Cunningham P; Thomas J; Gross U; Gaskins D; Sash C; Parker K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1874-8. PubMed ID: 3547892
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-thymocyte globulins: clinical trials during kidney transplantation].
    Murisasco A; Pollini J; Saingra S; Barnouin F; Lafon S; Mostefa-Kara S; Latour M
    Mars Med; 1972; 109(9):541-8. PubMed ID: 4565307
    [No Abstract]   [Full Text] [Related]  

  • 6. Tolerance and suppressor T cells.
    Brent L
    Proc Eur Dial Transplant Assoc; 1977; 14():245-50. PubMed ID: 341124
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo - in vitro correlates of antithymocyte globulin (ATG) immunosuppression in the human.
    Thomas F; Berry R; Mendez-Picon G; Thomas J; Lower RR; Lee HM
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():56-61. PubMed ID: 386321
    [No Abstract]   [Full Text] [Related]  

  • 8. Antirejection treatment with anti-thymocyte globulin in renal transplant recipients treated with cyclosporine as basic immunosuppression.
    Hoitsma AJ; Wetzels JF; Berden JH; Koene RA
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):12-3. PubMed ID: 3051578
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of acute rejection of renal allografts with antithymocyte globulin or high-dosage prednisone. Influence of recipient DRw6 and DR matching.
    Hoitsma AJ; Van Lier HJ; Reekers P; Koene RA
    Neth J Med; 1985; 28(6):239-42. PubMed ID: 3892324
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimization of antilymphocyte globulin in renal transplantation.
    Fries D; Hiesse C; Lantz O; Daoud M; Rousseau P; Manseur N; Richalet B; Benoit G; Charpentier B; Eygonnet JP
    Transplant Proc; 1990 Aug; 22(4):1793-4. PubMed ID: 2389452
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic monitoring parameters in ALG- versus non-ALG-treated renal transplant patients.
    McAlack RF; Stern S; Beizer R; Sklar L; Bannett A
    Transplant Proc; 1979 Jun; 11(2):1431-2. PubMed ID: 382532
    [No Abstract]   [Full Text] [Related]  

  • 12. Pancreas transplant outcome with or without biological anti-T-cell therapy for induction immunosuppression with use of cyclosporine.
    Sutherland DE; Moudry-Munns KC; Gruessner A
    Transplant Proc; 1994 Oct; 26(5):2752-5. PubMed ID: 7940866
    [No Abstract]   [Full Text] [Related]  

  • 13. Semi-specific immunosuppression in canine kidney allograft with I131 labelled ATG.
    Corman J; Smeesters C; Giroux L; St-Louis G; Leveille M; Lavigne CM; Lamoureux J; Jean G; Daloze P
    Transplant Proc; 1982 Dec; 14(4):656-8. PubMed ID: 6188256
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous antilymphocyte globulin in human cadaveric renal allotransplantation. Clinical and immunologic observations.
    Collste LG
    Acta Chir Scand; 1972; 138(8):765-74. PubMed ID: 4565721
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antilymphocytic globulin (GAL). Clinical use in 18 renal transplantation patients].
    Galvão MM; Mendes NF; Ramos OL; Sabbaga E
    Rev Bras Pesqui Med Biol; 1972; 5(5):251-8. PubMed ID: 4573042
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction immunosuppression with antithymocyte globulin in renal transplantation using a variable dose according to the absolute number of CD3+ T cells.
    Abouna GM; Kumar MS; al-Abdullah IH; Loose J; Sullivan DK; Phillips K; Yost S; Seirka D
    Transplant Proc; 1995 Oct; 27(5):2676-8. PubMed ID: 7482872
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined pancreas-kidney transplants using quadruple immunosuppression therapy: a comparison between antilymphoblast and antithymocyte globulins.
    Fasola CG; Hricik DE; Schulak JA
    Transplant Proc; 1995 Dec; 27(6):3135-6. PubMed ID: 8539880
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful pancreas-renal transplantation without anti-T-cell antibody induction.
    Shapiro ME; Abrams JM; Brown RS; Steinman TI; Strom TB
    Transplant Proc; 1995 Dec; 27(6):3087-8. PubMed ID: 8539857
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of graft inoculation with donor bone marrow cells on kidney allograft survival in antilymphocyte serum-treated rats.
    Otsu I; Gottschalk R; Monaco AP
    Transplant Proc; 1994 Oct; 26(5):3060. PubMed ID: 7940962
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunomodulation of T cells by thymic hormone and monoclonal anti-T cell antibody.
    Bach JF; Dardenne M; Chatenoud L
    Transplant Proc; 1982 Sep; 14(3):509-12. PubMed ID: 6758237
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.